Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
- 1 April 1996
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 58 (20) , 1777-1784
- https://doi.org/10.1016/0024-3205(96)00160-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A comparison of HPLC and bioassay methods for plasma melanotan‐II (MT‐II) determination: Application to a pharmacokinetic study in ratsBiopharmaceutics & Drug Disposition, 1994
- Administration of melanotropic peptides during gestation in the rodentToxicology, 1993
- Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropinPublished by American Medical Association (AMA) ,1991
- Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamicsJournal of Medicinal Chemistry, 1989
- Linear and Cyclic α‐Melanotropin [4–10]‐Fragment Analogues That Exhibit Superpotency and Residual ActivityPigment Cell Research, 1989
- Design of a new class of superpotent cyclic .alpha.-melanotropins based on quenched dynamic simulationsJournal of the American Chemical Society, 1989
- Toxicologic studies of a superpotent α-melanotropin, [Nle4, D-Phe7]α-MSHInvestigational New Drugs, 1988
- The validity and practicality of sun-reactive skin types I through VIArchives of Dermatology, 1988
- Insulin and glucagon binding to isolated hepatocytes of egyptian sand rats (Psammomys obesus): Evidence for an insulin receptor defectComparative Biochemistry and Physiology Part A: Physiology, 1983
- Comparative biological activities of highly potent active-site analogs of .alpha.-melanotropinJournal of Medicinal Chemistry, 1982